Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesenchymal stem cells: heading into the clinic.

O N Koç1, H M Lazarus

  • 1Department of Medicine, The Ireland Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, OH 44106, USA.

Bone Marrow Transplantation
|March 30, 2001
PubMed
Summary

Mesenchymal stem cells (MSCs) from bone marrow support blood formation and can become bone, cartilage, and fat cells. This review explores their therapeutic potential in stem cell transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive post-remission therapy does not decrease relapse after allotransplants for acute myeloid leukaemia in 1st remission and should not be given.

Leukemia·2025
Same author

Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.

Bone marrow transplantation·2024
Same author

Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.

Bone marrow transplantation·2024
Same author

A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy.

Leukemia·2024
Same author

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Current oncology (Toronto, Ont.)·2020
Same author

Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin.

Clinical and experimental dermatology·2018

Area of Science:

  • Stem Cell Biology
  • Hematopoietic Stem Cell Transplantation

Background:

  • Bone marrow contains non-hematopoietic pluripotent progenitor cells.
  • Mesenchymal stem cells (MSCs) are key non-hematopoietic progenitors, extensively studied for their properties.
  • MSCs possess the capacity to support hematopoiesis and differentiate into various cell types.

Purpose of the Study:

  • To review the current understanding of bone marrow stroma.
  • To discuss mesenchymal stem cells (MSCs) and their characteristics.
  • To explore the therapeutic applications of MSCs in hematopoietic stem cell transplantation.

Main Methods:

  • Literature review of bone marrow stroma and MSCs.
  • Analysis of MSC differentiation capabilities.
  • Evaluation of MSCs' role in hematopoietic stem cell transplantation.

Main Results:

  • Mesenchymal stem cells (MSCs) are well-characterized non-hematopoietic progenitors in bone marrow.
  • MSCs support hematopoiesis and exhibit multipotency, differentiating into osteocytes, chondrocytes, tenocytes, and adipocytes.
  • The potential therapeutic role of MSCs in hematopoietic stem cell transplantation is a significant area of research.

Conclusions:

  • Mesenchymal stem cells (MSCs) are crucial components of the bone marrow microenvironment.
  • Their supportive and differentiative capacities highlight their therapeutic promise.
  • Further research into MSCs can advance hematopoietic stem cell transplantation outcomes.

Related Experiment Videos